JP2011518173A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011518173A5 JP2011518173A5 JP2011505181A JP2011505181A JP2011518173A5 JP 2011518173 A5 JP2011518173 A5 JP 2011518173A5 JP 2011505181 A JP2011505181 A JP 2011505181A JP 2011505181 A JP2011505181 A JP 2011505181A JP 2011518173 A5 JP2011518173 A5 JP 2011518173A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- indole
- alkylene
- ethyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 25
- -1 alkyl Compound Chemical class 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 150000001204 N-oxides Chemical class 0.000 claims 2
- 208000000389 T-Cell Leukemia Diseases 0.000 claims 2
- 206010042971 T-cell lymphoma Diseases 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005842 heteroatoms Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Chemical group 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 28
- 238000003786 synthesis reaction Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000012044 organic layer Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000002194 synthesizing Effects 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000006751 Mitsunobu reaction Methods 0.000 description 4
- 239000008079 hexane Substances 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-Hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- JNWBBCNCSMBKNE-UHFFFAOYSA-N HATU Chemical compound F[P-](F)(F)(F)(F)F.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 JNWBBCNCSMBKNE-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- ZSKGQVFRTSEPJT-UHFFFAOYSA-N pyrrole-2-carboxaldehyde Chemical compound O=CC1=CC=CN1 ZSKGQVFRTSEPJT-UHFFFAOYSA-N 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- HIZSJRADKKBIBA-VOTSOKGWSA-N (E)-3-[1-[2-(3-fluorophenoxy)ethyl]pyrrol-2-yl]-N-hydroxyprop-2-enamide Chemical compound ONC(=O)\C=C\C1=CC=CN1CCOC1=CC=CC(F)=C1 HIZSJRADKKBIBA-VOTSOKGWSA-N 0.000 description 1
- KUIDHMIWFNGQKB-VOTSOKGWSA-N (E)-3-[1-[2-(3-fluorophenoxy)ethyl]pyrrol-2-yl]prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=CN1CCOC1=CC=CC(F)=C1 KUIDHMIWFNGQKB-VOTSOKGWSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-Dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- LNWXALCHPJANMJ-UHFFFAOYSA-N 1-(bromomethyl)-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(CBr)=C1 LNWXALCHPJANMJ-UHFFFAOYSA-N 0.000 description 1
- 125000006016 2-bromoethoxy group Chemical group 0.000 description 1
- JBKINHFZTVLNEM-UHFFFAOYSA-N 2-bromoethoxy-tert-butyl-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCCBr JBKINHFZTVLNEM-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- FYSRAGLPXRVAPN-UHFFFAOYSA-N 3-(2-bromoethoxy)benzaldehyde Chemical compound BrCCOC1=CC=CC(C=O)=C1 FYSRAGLPXRVAPN-UHFFFAOYSA-N 0.000 description 1
- IAVREABSGIHHMO-UHFFFAOYSA-N 3-Hydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1 IAVREABSGIHHMO-UHFFFAOYSA-N 0.000 description 1
- XFHTVCMRNSBQCF-UHFFFAOYSA-N 4-(2-bromoethoxy)benzaldehyde Chemical compound BrCCOC1=CC=C(C=O)C=C1 XFHTVCMRNSBQCF-UHFFFAOYSA-N 0.000 description 1
- WGQKYBSKWIADBV-UHFFFAOYSA-N Benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- UBHZUDXTHNMNLD-UHFFFAOYSA-N dimethylsilane Chemical compound C[SiH2]C UBHZUDXTHNMNLD-UHFFFAOYSA-N 0.000 description 1
- ADXAVDLMQIGVDB-UHFFFAOYSA-N ethyl 3-(benzylamino)-4-nitrobenzoate Chemical compound CCOC(=O)C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 ADXAVDLMQIGVDB-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- CTFHWBBSQCPUEW-UHFFFAOYSA-N methyl 1-(2-hydroxyethyl)indole-6-carboxylate Chemical compound COC(=O)C1=CC=C2C=CN(CCO)C2=C1 CTFHWBBSQCPUEW-UHFFFAOYSA-N 0.000 description 1
- FGZCYRGXDOMXNB-UHFFFAOYSA-N methyl 1-[2-(3-chlorophenoxy)ethyl]indole-6-carboxylate Chemical compound C12=CC(C(=O)OC)=CC=C2C=CN1CCOC1=CC=CC(Cl)=C1 FGZCYRGXDOMXNB-UHFFFAOYSA-N 0.000 description 1
- AYYOZKHMSABVRP-UHFFFAOYSA-N methyl 1H-indole-6-carboxylate Chemical compound COC(=O)C1=CC=C2C=CNC2=C1 AYYOZKHMSABVRP-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- BZKBCQXYZZXSCO-UHFFFAOYSA-N sodium hydride Inorganic materials [H-].[Na+] BZKBCQXYZZXSCO-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- BXYXWBBROYOLIG-UHFFFAOYSA-N tert-butyl-ethoxy-dimethylsilane Chemical compound CCO[Si](C)(C)C(C)(C)C BXYXWBBROYOLIG-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4519808P | 2008-04-15 | 2008-04-15 | |
| US61/045,198 | 2008-04-15 | ||
| PCT/US2009/040709 WO2009129335A2 (fr) | 2008-04-15 | 2009-04-15 | Inhibiteurs sélectifs de l'histone désacétylase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014224779A Division JP2015057414A (ja) | 2008-04-15 | 2014-11-04 | ヒストン脱アセチル化酵素の選択的インヒビター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011518173A JP2011518173A (ja) | 2011-06-23 |
| JP2011518173A5 true JP2011518173A5 (fr) | 2014-12-25 |
| JP5670877B2 JP5670877B2 (ja) | 2015-02-18 |
Family
ID=41199715
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011505181A Active JP5670877B2 (ja) | 2008-04-15 | 2009-04-15 | ヒストン脱アセチル化酵素の選択的インヒビター |
| JP2014224779A Pending JP2015057414A (ja) | 2008-04-15 | 2014-11-04 | ヒストン脱アセチル化酵素の選択的インヒビター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014224779A Pending JP2015057414A (ja) | 2008-04-15 | 2014-11-04 | ヒストン脱アセチル化酵素の選択的インヒビター |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8466193B2 (fr) |
| EP (1) | EP2265590B8 (fr) |
| JP (2) | JP5670877B2 (fr) |
| CA (2) | CA2721218C (fr) |
| ES (1) | ES2575873T3 (fr) |
| MX (1) | MX2010011168A (fr) |
| WO (1) | WO2009129335A2 (fr) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8466193B2 (en) | 2008-04-15 | 2013-06-18 | Pharmacyclics, Inc. | Selective inhibitors of histone deacetylase |
| EP2445340B1 (fr) | 2009-06-22 | 2016-05-18 | Millennium Pharmaceuticals, Inc. | Acides hydroxamiques substitués et leurs utilisations |
| WO2010151317A1 (fr) | 2009-06-22 | 2010-12-29 | Millennium Pharmaceuticals, Inc. | Acides hydroxamiques substitués et leurs utilisations |
| US8546588B2 (en) | 2010-02-26 | 2013-10-01 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| TWI429628B (zh) * | 2010-03-29 | 2014-03-11 | Univ Taipei Medical | 吲哚基或吲哚啉基羥肟酸化合物 |
| WO2011130163A1 (fr) | 2010-04-12 | 2011-10-20 | Millennium Pharmaceuticals, Inc. | Acides hydroxamiques substitués et leurs utilisations |
| AU2011239537A1 (en) * | 2010-04-16 | 2012-11-15 | Curis, Inc. | Treatment of cancers having K-ras mutations |
| US8471026B2 (en) | 2010-08-26 | 2013-06-25 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| US8765773B2 (en) | 2010-10-18 | 2014-07-01 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| WO2012088015A2 (fr) | 2010-12-22 | 2012-06-28 | Millennium Pharmaceuticals, Inc. | Acides hydroxamiques substitués et leurs utilisations |
| US8404738B2 (en) | 2011-01-21 | 2013-03-26 | Hoffmann-La Roche Inc. | 4-amino-N-hydroxy-benzamides for the treatment of cancer |
| CN103328446B (zh) * | 2011-01-21 | 2016-01-20 | 霍夫曼-拉罗奇有限公司 | 用于治疗癌症的新的4-氨基-n-羟基-苯甲酰胺 |
| JP5990106B2 (ja) * | 2011-01-28 | 2016-09-07 | 佐藤製薬株式会社 | 縮環化合物 |
| EP2714688B1 (fr) | 2011-05-26 | 2016-02-24 | Daiichi Sankyo Company, Limited | Composés hétérocycliques comme inhibiteurs de proteines kinases |
| CN102838625B (zh) * | 2011-06-22 | 2015-04-15 | 中国科学院上海药物研究所 | 四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途 |
| EP2723338A2 (fr) * | 2011-06-24 | 2014-04-30 | The Trustees of Stevens Institute of Technology | Inhibiteurs sélectifs de l'isoforme 6 de l'histone désacétylase et procédés associés |
| US20140315889A1 (en) * | 2011-10-28 | 2014-10-23 | Chong Kun Dang Pharmaceutical Corp. | Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof |
| WO2013169858A1 (fr) | 2012-05-08 | 2013-11-14 | The Broad Institute, Inc. | Méthodes de diagnostic et de traitement chez des patients ayant ou présentant un risque de développer une résistance à une thérapie anticancéreuse |
| TWI692469B (zh) | 2012-11-09 | 2020-05-01 | 南韓商Ｌｇ化學股份有限公司 | Ｇｐｒ４０受體促效劑，製造該促效劑的方法以及含有該促效劑作爲活性劑的醫藥組成物 |
| CN103086971B (zh) * | 2013-01-11 | 2015-08-26 | 中国科学院广州生物医药与健康研究院 | 含氮杂环衍生物,其制备方法及其在制备组蛋白去乙酰化酶ⅰ抑制剂中的应用 |
| CA2903473A1 (fr) * | 2013-03-12 | 2014-10-09 | Quanticel Pharmaceuticals, Inc. | Inhibiteurs d'histone demethylase |
| EP3052655B1 (fr) | 2013-09-30 | 2018-11-07 | Institute For Cancer Research D/b/a The Research Institute of Fox Chase Cancer Center | Closantel en combinaison avec temozolomide pour le traitement d'un cancer exprimant la thymine dna glycosylase |
| WO2017077008A1 (fr) | 2015-11-03 | 2017-05-11 | Hochschule Darmstadt | Inhibiteurs de hdac8 sélectifs et leurs utilisations |
| EP3394052B1 (fr) | 2015-12-22 | 2021-07-28 | Kancera AB | Acides hydroxamiques bicyclique utilisés comme inhibiteurs de l'activité de l'histone désacétylase d'un mammifère |
| WO2017143237A1 (fr) * | 2016-02-17 | 2017-08-24 | Acetylon Pharmaceuticals, Inc. | Augmentation de l'expression de gènes régulés par l'interféron à l'aide de combinaisons d'inhibiteurs de l'histone désacétylase et de médicaments immunomodulateurs |
| CN106478606B (zh) * | 2016-09-21 | 2019-05-10 | 沈阳药科大学 | N-取代吲哚类衍生物及其应用 |
| WO2018165520A1 (fr) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Composés inhibiteurs de métalloenzymes |
| CN109568302B (zh) * | 2018-11-01 | 2021-07-16 | 郑州大学第一附属医院 | 一种治疗晚期肝癌的药物复合物及其应用 |
| WO2020113094A1 (fr) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Composés pyrrole et pyrazole et leurs procédés d'utilisation |
| WO2021186855A1 (fr) * | 2020-03-16 | 2021-09-23 | 株式会社マンダム | Procédé de détection d'un indicateur de lymphome à lymphocytes t et son utilisation |
| US11007187B1 (en) * | 2020-03-25 | 2021-05-18 | Therapeutica Borealis Oy | Medicine for Covid-19 and treatment |
| US11638722B2 (en) | 2020-03-25 | 2023-05-02 | Therapeutica Borealis Oy C/O Avance Attorneys Ltd. | Medicine for Covid-19 and treatment |
| US11278602B2 (en) | 2020-03-25 | 2022-03-22 | Therapeutica Borealis Oy | Medicine for Covid-19 and treatment |
| CN111518031B (zh) * | 2020-05-29 | 2023-01-17 | 中国药科大学 | 一种含有异羟肟酸的化合物及其制备方法、应用 |
| WO2023078252A1 (fr) | 2021-11-02 | 2023-05-11 | Flare Therapeutics Inc. | Agonistes inverses de pparg et leurs utilisations |
| CN114409638B (zh) * | 2022-02-09 | 2023-02-14 | 深圳大学 | 组蛋白去乙酰化酶8选择性降解剂、制备方法及其在抗肿瘤活性中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9523946D0 (en) | 1995-11-23 | 1996-01-24 | Bayer Ag | Leukotriene antagonistic benzoic acid derivatives |
| IL144578A0 (en) | 1999-01-29 | 2002-05-23 | Imclone Systems Inc | Antibodies specific to kdr and uses thereof |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| AU4972900A (en) | 1999-04-08 | 2000-11-14 | Arch Development Corporation | Use of anti-vegf antibody to enhance radiation in cancer therapy |
| US6875598B1 (en) | 1999-12-08 | 2005-04-05 | Applera Corporation | Histone deacetylase-8 proteins, nuclei acids, and methods for use |
| JP2003083067A (ja) * | 2001-09-13 | 2003-03-19 | Toyota Motor Corp | 内燃機関のピストン温度制御装置 |
| WO2003083067A2 (fr) * | 2002-03-28 | 2003-10-09 | Brigham And Women's Hospital, Inc. | Inhibiteurs d'histone deacetylase permettant de traiter la sclerose en plaques, la sclerose laterale amyotrophique et la maladie d'alzheimer |
| DK1673349T3 (da) * | 2003-09-22 | 2010-10-25 | S Bio Pte Ltd | Benzimidazolderivater: fremstilling og farmaceutiske anvendelser |
| US20050137234A1 (en) | 2003-12-19 | 2005-06-23 | Syrrx, Inc. | Histone deacetylase inhibitors |
| WO2007109178A2 (fr) * | 2006-03-16 | 2007-09-27 | Pharmacyclics, Inc. | Dérivés d'indole en tant qu'inhibiteurs de l'histone désacétylase |
| WO2008061160A1 (fr) * | 2006-11-14 | 2008-05-22 | Pharmacyclics, Inc. | Utilisations d'inhibiteurs sélectifs de hdac8 pour le traitement d'états inflammatoires |
| US7820711B2 (en) * | 2006-11-14 | 2010-10-26 | Pharmacyclics Inc. | Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders |
| US8466193B2 (en) | 2008-04-15 | 2013-06-18 | Pharmacyclics, Inc. | Selective inhibitors of histone deacetylase |
-
2009
- 2009-04-15 US US12/988,271 patent/US8466193B2/en active Active
- 2009-04-15 ES ES09733489.0T patent/ES2575873T3/es active Active
- 2009-04-15 JP JP2011505181A patent/JP5670877B2/ja active Active
- 2009-04-15 CA CA2721218A patent/CA2721218C/fr active Active
- 2009-04-15 WO PCT/US2009/040709 patent/WO2009129335A2/fr active Application Filing
- 2009-04-15 EP EP09733489.0A patent/EP2265590B8/fr active Active
- 2009-04-15 CA CA2875549A patent/CA2875549A1/fr not_active Abandoned
- 2009-04-15 MX MX2010011168A patent/MX2010011168A/es active IP Right Grant
-
2013
- 2013-05-20 US US13/897,582 patent/US8906954B2/en active Active
-
2014
- 2014-10-22 US US14/521,377 patent/US20150320758A1/en not_active Abandoned
- 2014-11-04 JP JP2014224779A patent/JP2015057414A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011518173A5 (fr) | ||
| ES2773686T3 (es) | Procesos para la preparación de (S)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina | |
| ES2585221T3 (es) | Un proceso para la preparación de 6-(7-((1-aminociclopropil)metoxi)-6-metoxiquinolin-4-iloxi)-n-metil-1-naftamida y productos intermedios sintéticos de la misma | |
| JP2008512379A (ja) | 置換２−（２，６−ジオキソピペリジン−３−イル）−１−オキソイソインドリン類の調製方法 | |
| JP2006312632A (ja) | テルミサルタンの調製方法 | |
| KR20080072738A (ko) | 아미도-페녹시벤조산 화합물의 제조를 위한 화학적 방법 | |
| KR20140008371A (ko) | 2-에톡시-1-((2''-((히드록시아미노)이미노메틸)비페닐-4-일)메틸)-1ｈ-벤조[ｄ]이미다졸-7-카르복시산과 그 에스테르를 제조하는 방법 | |
| HUE030696T2 (en) | Process for the preparation of dabigatran etexilate and its intermediates | |
| JP2015151395A (ja) | アドレナリン拮抗薬の調製方法 | |
| US10099981B2 (en) | Methods for meta-arylation of aromatic alcohols | |
| US20080076932A1 (en) | A process for the preparation of phenyltetrazole compounds | |
| JP2004196678A (ja) | ピラゾール系誘導体 | |
| RU2695383C2 (ru) | Производные бендамустина, родственные соединения и их медицинское применение для лечения рака | |
| HU214883B (hu) | Eljárás 2-aril-5-(trifluor-metil)-2-pirrolin vegyületek előállitására | |
| AU594858B2 (en) | Process and intermediates for quinolonecarboxylic acid | |
| MX2012009413A (es) | Procedimiento para la preparacion de 2-(ciclohexilmetil)-n-{2[(2s) -1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolina-7-su lfonamida. | |
| JP2019522662A (ja) | ベムラフェニブの新規な製造方法 | |
| JP7252978B2 (ja) | ２－（１－（ｔｅｒｔ－ブトキシカルボニル）ピペリジン－４－イル）安息香酸を調製するためのプロセス | |
| JP5870114B2 (ja) | 鏡像異性的に純粋なビナフトール誘導体およびその製造方法（ｅｎａｎｔｉｏｍｅｒｉｃａｌｌｙ ｐｕｒｅ ｂｉｎａｐｈｔｏｌ ｄｅｒｉｖａｔｉｖｅｓ ａｎｄ ｍｅｔｈｏｄ ｆｏｒ ｐｒｅｐａｒｉｎｇ ｔｈｅ ｓａｅ） | |
| WO2005021465A1 (fr) | Procede de production de compose insature aromatique | |
| JP4518066B2 (ja) | ジアルコキシニトリル誘導体及びその製法 | |
| WO2005063678A1 (fr) | Procede de production d'un derive de l'acide phenylacetique | |
| JP4518065B2 (ja) | 新規ジアルコキシアミドオキシム誘導体及びその製法 | |
| CA3214107A1 (fr) | Nouveau procede de synthese de derives de 5-{5-chloro-2-[(3s)-3-[(morpholin-4-yl)methyl]-3,4-dihydroisoquinoleine-2(1h)-carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-acide carboxylique et son application pour la production de composes pharmaceutiques | |
| WO2013026357A1 (fr) | Procédé de préparation de dérivés d'imidazole |